Daily Archives: October 27, 2020

doTERRA Once Again Recognized as Global Aromatherapy and Essential Oils Leader

Verify Markets cites doTERRA as the “singular reason for rapid market expansion,” awards doTERRA with 2020 Verified Market Leader Award Verify Markets Global Aromatherapy and Essential Oils Market Report Verify Markets awards doTERRA as the 2020 Verified Market Leader and cites doTERRA as the “singular reason for rapid market expansion.” PLEASANT GROVE, Utah, Oct. 27,

WillScot Mobile Mini Holdings to Participate in the Baird 2020 Global Industrials Conference

PHOENIX, Oct. 27, 2020 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini Holdings” or the “Company”) (Nasdaq: WSC), a North American leader in turnkey modular space and portable storage solutions, today announced that Brad Soultz, Chief Executive Officer, and Tim Boswell, Chief Financial Officer, will host virtual private meetings and participate in

VistaJet Reveals Its Private World

A gateway to the world’s most revered properties and destinations to make private travel simple VistaJet Private World Global 7500 VistaJet-to-Estate Private World VistaJet-to-Suite Private World VistaJet-to-Island Private World LONDON, Oct. 27, 2020 (GLOBE NEWSWIRE) — As privacy and safety become increasingly important for global travelers12 VistaJet, the first and only global business aviation company, announces Private World and

UPDATE – New Cryptocurrency Mining Era with ASICLine

TOKYO, Oct. 27, 2020 (GLOBE NEWSWIRE) — ASICLine ( https://asicline.com ) has recently pioneered a new era in the world of cryptocurrency mining with the official launch of its two miners FirstLine and PowerBox. These advanced range of 5nm ASIC miners make crypto mining simple, affordable, and profitable like never before, with several features that are unheard of in the industry. Hash rate and power consumption are

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

5,500 volunteers enrolled to date in pivotal Phase 3 clinical trial in the U.K. Study expanded to 15,000 participants Full enrollment expected by end of November Event-driven interim data expected as soon as early first quarter 2021 U.S. pivotal Phase 3 clinical trial planned to begin by end of November Significant progress in large-scale manufacturing